1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. WIDE RANGE OF APPLICATIONS
3.2.2. GROWING DEMAND FOR SYNTHETIC HYDROGELS FOR RESEARCH
3.2.3. GROWTH IN PERSONAL CARE & HYGIENE SECTOR
3.2.4. UPSURGE IN CHRONIC CONDITIONS
3.3. KEY RESTRAINTS
3.3.1. ENVIRONMENTAL HAZARD
3.3.2. HIGH PRODUCTION COST

4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER'S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE

5. MARKET BY FORM
5.1. AMORPHOUS HYDROGELS
5.2. SEMI-CRYSTALLINE HYDROGELS
5.3. CRYSTALLINE HYDROGELS

6. MARKET BY RAW MATERIALS
6.1. SYNTHETIC
6.2. NATURAL
6.3. HYBRID HYDROGELS

7. MARKET BY COMPOSITION
7.1. POLYACRYLATE
7.2. POLYACRYLAMIDE
7.3. SILICONE-MODIFIED HYDROGELS
7.4. AGAR-BASED
7.5. OTHERS

8. MARKET BY PRODUCT
8.1. SEMI-CRYSTALLINE BUTTONS
8.2. AMORPHOUS GELS
8.3. IMPREGNATED GAUZE
8.4. FILMS & MATRICES
8.5. HYDROGEL SHEETS

9. MARKET BY END-USER
9.1. CONTACT LENSES
9.2. HYGIENE PRODUCTS
9.3. WOUND CARE
9.4. DRUG DELIVERY
9.5. TISSUE ENGINEERING
9.6. OTHERS

10. GEOGRAPHICAL ANALYSIS
10.1. EUROPE
10.1.1. UNITED KINGDOM
10.1.2. GERMANY
10.1.3. FRANCE
10.1.4. ITALY
10.1.5. RUSSIA
10.1.6. BELGIUM
10.1.7. POLAND
10.1.8. REST OF EUROPE

11. COMPANY PROFILES
11.1. ASHLAND EUROPE HOLDINGS INC
11.2. B BRAUN HOLDING GMBH &CO KG
11.3. CARDINAL HEALTH
11.4. ESSITY
11.5. MEDLINE INDUSTRIES INC
11.6. PAUL HARTMAN
11.7. PROCYON CORPORATION
11.8. SMITH & NEPHEW
11.9. THE COOPER COMPANIES
11.10. 3M COMPANY
11.11. JOHNSON & JOHNSON
11.12. ROYAL DSM
11.13. MEDTRONIC PLC
11.14. DOW CORNING
11.15. MOMENTIVE PERFORMANCE MATERIALS
11.16. DERMA SCIENCES
11.17. COLOPLAST
11.18. HOYA CORPORATION
11.19. INTEGRA LIFESCIENCES
11.20. ALCON (NOVARTIS AG)